Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahin Lockman

Showing results (101-110 of 268) with videos related to

Pageof 27
Sort By:
Journal of the International AIDS Society|September 19, 2019
Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?Lee Fairlie, Catriona Waitt, Shahin Lockman, et al.
Journal of the International AIDS Society|June 2, 2015
Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana communityVlad Novitsky, Hermann Bussmann, Lillian Okui, et al.
BMC Public Health|January 18, 2016
Unintended pregnancy, contraceptive use, and childbearing desires among HIV-infected and HIV-uninfected women in Botswana: across-sectional studyGloria K Mayondi, Kathleen Wirth, Chelsea Morroni, et al.
Plos One|August 13, 2015
Cancer Incidence following Expansion of HIV Treatment in BotswanaScott Dryden-Peterson, Heluf Medhin, Malebogo Kebabonye-Pusoentsi, et al.
Plos One|March 27, 2024
Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ARTMaureen Sakoi-Mosetlhi, Gbolahan Ajibola, Roxanna Haghighat, et al.
Journal of the International AIDS Society|February 25, 2020
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?Diane Havlir, Shahin Lockman, Helen Ayles, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in BotswanaKathleen Powis, Shahin Lockman, Laura Smeaton, et al.
Plos One|March 25, 2017
Detecting congenital malformations - Lessons learned from the Mpepu study, BotswanaGbolahan Ajibola, Rebecca Zash, Roger L Shapiro, et al.
The Journal of Infectious Diseases|January 21, 2014
Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVPValerie F Boltz, Yajing Bao, Shahin Lockman, et al.
BMC Public Health|January 16, 2024
Self-reported cardiovascular disease risk factor screening among people living with HIV vs. members of the general population in Botswana: a community-based studyOnkabetse Julia Molefe-Baikai, Kago Kebotsamang, Pinkie Modisawakgomo, et al.
Pageof 27

Showing results (101-110 of 268) with videos related to

Sort By:
Pageof 27
Journal of the International AIDS Society|September 19, 2019
Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?Lee Fairlie, Catriona Waitt, Shahin Lockman, et al.
Journal of the International AIDS Society|June 2, 2015
Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana communityVlad Novitsky, Hermann Bussmann, Lillian Okui, et al.
BMC Public Health|January 18, 2016
Unintended pregnancy, contraceptive use, and childbearing desires among HIV-infected and HIV-uninfected women in Botswana: across-sectional studyGloria K Mayondi, Kathleen Wirth, Chelsea Morroni, et al.
Plos One|August 13, 2015
Cancer Incidence following Expansion of HIV Treatment in BotswanaScott Dryden-Peterson, Heluf Medhin, Malebogo Kebabonye-Pusoentsi, et al.
Plos One|March 27, 2024
Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ARTMaureen Sakoi-Mosetlhi, Gbolahan Ajibola, Roxanna Haghighat, et al.
Journal of the International AIDS Society|February 25, 2020
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?Diane Havlir, Shahin Lockman, Helen Ayles, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in BotswanaKathleen Powis, Shahin Lockman, Laura Smeaton, et al.
Plos One|March 25, 2017
Detecting congenital malformations - Lessons learned from the Mpepu study, BotswanaGbolahan Ajibola, Rebecca Zash, Roger L Shapiro, et al.
The Journal of Infectious Diseases|January 21, 2014
Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVPValerie F Boltz, Yajing Bao, Shahin Lockman, et al.
BMC Public Health|January 16, 2024
Self-reported cardiovascular disease risk factor screening among people living with HIV vs. members of the general population in Botswana: a community-based studyOnkabetse Julia Molefe-Baikai, Kago Kebotsamang, Pinkie Modisawakgomo, et al.
Pageof 27